We are fortunate to have had a number of truly outstanding, and diverse, speakers in the last couple of years. Stay tuned for more to come!
April 2021
Julie K Schwarz, MD PhD, WashU
Using Imaging and Genomics to define Biomarkers of Radiation Sensitivity in Gynecologic Cancers
September 2021
Meredith A Morgan, PhD, UMich
Enhancing radiation-induced immunity with inhibitors of the DNA damage response in pancreatic cancer
January 2022
Timothy A Chan, MD PhD, Cleveland Clinic
How Immune Cells Recognize Tumor Cells and Why It Matters in Radiation Oncology
April 2022
Anthony Chalmers, MD PhD, U Glasgow
Combining radiation therapy with inhibitors of the DNA damage response in glioblastoma and other cancers: a ‘bench-to-bedside’ odyssey’
September 2022
Ralph Weichselbaum, MD PhD, U Chicago
Oligometastatic Cancer: Illusion or Reality
January 2023
David S Yu, MD PhD, Emory
Understanding and Exploiting the DNA Damage Response for Cancer Therapy
April 2023
Freddy E Escorcia, MD, PhD, NCI
Radiation Oncology meets Radiopharmaceuticals for Hepatocellular Carcinoma *In Person*